| Primary |
| Hormone Replacement Therapy |
70.6% |
| Oestrogen Replacement Therapy |
9.6% |
| Menopausal Symptoms |
5.6% |
| Menopause |
3.7% |
| Blood Cholesterol Increased |
1.9% |
| Thyroid Disorder |
1.9% |
| Hot Flush |
1.5% |
| Hypertension |
0.9% |
| Asthma |
0.6% |
| Product Used For Unknown Indication |
0.6% |
| Depression |
0.3% |
| Hormone Therapy |
0.3% |
| Hypersensitivity |
0.3% |
| Hypothyroidism |
0.3% |
| Insomnia |
0.3% |
| Menstruation Irregular |
0.3% |
| Metrorrhagia |
0.3% |
| Mitral Valve Prolapse |
0.3% |
| Osteoporosis |
0.3% |
| Ovarian Failure |
0.3% |
|
| Breast Cancer |
62.2% |
| Breast Cancer Metastatic |
15.1% |
| Breast Cancer Female |
4.0% |
| Pulmonary Embolism |
2.5% |
| Breast Cancer In Situ |
1.5% |
| Ovarian Cancer |
1.5% |
| Progesterone Receptor Assay Positive |
1.5% |
| Swelling Face |
1.5% |
| Breast Cancer Recurrent |
1.2% |
| Hot Flush |
1.2% |
| Ovarian Cancer Recurrent |
1.2% |
| Thrombosis |
1.2% |
| Retracted Nipple |
0.9% |
| Cerebrovascular Accident |
0.6% |
| Endometrial Cancer |
0.6% |
| Metrorrhagia |
0.6% |
| Oestrogen Receptor Assay Positive |
0.6% |
| Seroma |
0.6% |
| Vaginal Haemorrhage |
0.6% |
| Visual Acuity Reduced |
0.6% |
|
| Secondary |
| Hormone Replacement Therapy |
82.2% |
| Menopausal Symptoms |
5.2% |
| Menopause |
4.5% |
| Hypertension |
1.4% |
| Oestrogen Replacement Therapy |
1.2% |
| Depression |
1.0% |
| Hormone Therapy |
0.6% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Osteoporosis Prophylaxis |
0.4% |
| Anxiety |
0.3% |
| Hypothyroidism |
0.3% |
| Mood Swings |
0.3% |
| Asthma |
0.3% |
| Hot Flush |
0.3% |
| Postmenopause |
0.3% |
| Thyroid Disorder |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Osteoporosis |
0.3% |
| Hypersensitivity |
0.2% |
| Pain |
0.2% |
|
| Breast Cancer Female |
41.8% |
| Breast Cancer |
35.6% |
| Breast Cancer Metastatic |
8.9% |
| Ovarian Cancer |
2.0% |
| Contralateral Breast Cancer |
1.2% |
| Progesterone Receptor Assay Positive |
1.2% |
| Medication Residue |
1.1% |
| Cerebrovascular Accident |
0.9% |
| Deep Vein Thrombosis |
0.9% |
| Pulmonary Embolism |
0.9% |
| Vascular Dementia |
0.9% |
| Vulvovaginal Dryness |
0.9% |
| Vomiting |
0.7% |
| Systemic Lupus Erythematosus |
0.5% |
| Thrombosis |
0.5% |
| Uterine Leiomyoma |
0.5% |
| Breast Cancer In Situ |
0.4% |
| Depression |
0.4% |
| Endometrial Cancer |
0.4% |
| Gallbladder Disorder |
0.4% |
|
| Concomitant |
| Parkinson's Disease |
19.7% |
| Anxiety |
8.8% |
| Hormone Replacement Therapy |
8.8% |
| Hypertension |
6.2% |
| Multiple Myeloma |
6.2% |
| Pain In Jaw |
6.2% |
| Drug Use For Unknown Indication |
5.7% |
| Depression |
5.2% |
| Constipation |
4.7% |
| Pain |
4.7% |
| Osteoporosis |
4.1% |
| Asthma |
3.6% |
| Arthritis |
2.6% |
| Sleep Disorder |
2.6% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hormone Therapy |
2.1% |
| Torticollis |
2.1% |
| Bronchitis |
1.6% |
| Hypersensitivity |
1.6% |
| Multiple Sclerosis |
1.6% |
|
| Withdrawal Of Life Support |
20.0% |
| Pathological Gambling |
11.1% |
| Weight Decreased |
11.1% |
| Paraesthesia |
6.7% |
| Breast Pain |
4.4% |
| Tricuspid Valve Incompetence |
4.4% |
| Vertigo |
4.4% |
| Vulvovaginal Discomfort |
4.4% |
| Weight Increased |
4.4% |
| Wheezing |
4.4% |
| Withdrawal Syndrome |
4.4% |
| Anaphylactic Reaction |
2.2% |
| Anosmia |
2.2% |
| Atrioventricular Block First Degree |
2.2% |
| Diabetes Mellitus |
2.2% |
| Gastrointestinal Disorder |
2.2% |
| Histoplasmosis Disseminated |
2.2% |
| Hypothyroidism |
2.2% |
| Infarction |
2.2% |
| Injury |
2.2% |
|
